Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Concentra Group Holdings Parent (CON) Shares Repurchased (2023 - 2026)

Concentra Group Holdings Parent (CON) reported Shares Repurchased of $15.0 million for Q1 2026, down 2.64% on a QoQ basis from $15.4 million in Q4 2024.

Concentra Group Holdings Parent (CON) has 3 years of Shares Repurchased data on file, last reported at $15.0 million in Q1 2026.

  • Quarterly Shares Repurchased changed N/A year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.1 million (changed N/A YoY) and the FY2025 annual result came in at $22.4 million, up 45.58% from the prior year.
  • Shares Repurchased eased to $15.0 million in Q1 2026 per CON's latest filing, from $15.4 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $15.4 million in Q4 2024 and bottomed at -$5.3 million in Q4 2023.
  • The 3-year median for Shares Repurchased is $15.0 million (2026), against an average of $8.4 million.
  • Peak annual rise in Shares Repurchased reached 389.42% in 2024, while the deepest fall reached 389.42% in 2024.
  • Tracing CON's Shares Repurchased over 3 years: stood at -$5.3 million in 2023, then soared by 389.42% to $15.4 million in 2024, then slipped by 2.64% to $15.0 million in 2026.
  • Per Business Quant, the three latest CON Shares Repurchased figures stand at $15.0 million (Q1 2026), $15.4 million (Q4 2024), and -$5.3 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn 1.57 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn 318.00 Mn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 196.37 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn 71.60 Mn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn -
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 163.85 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 190.04 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 Concentra Group Holdings Parent 3.13 Bn 3.07 Bn 170.47 Mn 15.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 15.00 Mn
Mar 31, 2026 15.00 Mn
Dec 31, 2024 15.40 Mn
Dec 31, 2024 15.40 Mn
Dec 31, 2023 -5.32 Mn
Dec 31, 2023 -5.32 Mn